The state of Connecticut currently has 25 active clinical trials seeking participants for Diabetes research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford.
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
NCT04219085
Recruiting
This study will utilize continuous glucose monitoring in women with A2 gestational diabetes. Women will be randomized to continuous glucose monitoring or routine care with fingersticks to check their blood glucose four times daily. It is hypothesized that women in the continuous glucose monitoring arm will have a lower incidence of the composite primary outcome, which includes the following variables: perinatal death, shoulder dystocia, birth weight greater than 4,000 grams, NICU admission for t... Read More
Gender:
FEMALE
Ages:
Between 18 years and 50 years
Trial Updated:
10/25/2024
Locations: Yale University, New Haven, Connecticut
Conditions: Gestational Diabetes, Maternal Complication of Pregnancy
Register for Updates